603676 Tibet Weixinkang Pharmaceutical
- 9.06
- +0.09+1.00%
About Tibet Weixinkang Pharmaceutical Company
The company is guided by clinical needs, based on R&D and innovation, and adhering to the combination of imitation. It is a comprehensive high-tech pharmaceutical enterprise integrating drug R&D, production and sales. It has significant advantages in the fields of intravenous vitamins, venous trace elements, and intravenous electrolytes. The company's main business is R&D, production and sales of chemical preparations and their APIs. The company's leading products include injectable multivitamin (12), multi-microelement injection, pediatric multivitamin injection (13), compound electrolyte injection (V), etc. Corporate honors: Inner Mongolia Baiyi Pharmaceutical Master's Student Practice Base; Inner Mongolia Baiyi Pharmaceutical 2015 Trustworthy A-Class Enterprise; New Potassium Biomedical Product Certificate; Inner Mongolia Baiyi Pharmaceutical High-tech Enterprise; Inner Mongolia Baiyi Pharmaceutical Received the Honest Enterprise Certificate, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- yong zhang
- Chairman，directors，general manager，Nomination Committee Members，Strategy Committee Members
- 3.00M
- feng liu
- Vice Chairman，directors，Deputy General Manager，Core technical personnel，Strategy Committee Members
- 1.40M
- binbin liu
- directors
- 1.40M
- shigong chen
- directors，Deputy General Manager，Remuneration and Assessment Committee Members
- 1.10M
- lei cao
- Independent directors，Remuneration and Assessment Committee Members，Nomination Committee Members，Audit Committee Members
- 170.00K
- xiaofang xu
- Independent directors，Audit Committee Members，Remuneration and Assessment Committee Members
- 170.00K
- yanping zhao
- Independent directors，Audit Committee Members，Strategy Committee Members，Nomination Committee Members
- 170.00K
- haibo yu
- Board Secretary
- 1.00M
- guotao ning
- Chairman of the Supervisory Board，Employee supervisors
- 634.80K
- jun wang
- auditors
- 546.50K
- wan luo
- auditors
- 254.80K
- xiaobing zhou
- Deputy General Manager
- 1.10M
- zizhong weng
- Deputy General Manager
- 1.12M
- yanxia zheng
- Chief Financial Officer
- 801.00K
Analysis
Price Target
No Data
